MedTrace Logo

Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging

NCT04910399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2024-01-09

No results posted yet for this study

Summary

This interventional, randomised, placebo-controlled and double-blind study aims to evaluate the effect of a dietary supplementation with a blue fish hydrolysate derived from marine by-products, containing peptides and n-3 polyunsaturated fatty acids, on cognitive performance in a healthy older population, between 60 and 73 years old, with lower memory performance.

Conditions

  • Memory Impairment
  • Age-related Cognitive Decline

Interventions

DIETARY_SUPPLEMENT

Blue fish hydrolysate

The experimental product is a dietary supplement composed of a hydrolysate of fatty blue fish containing low molecular weight peptides and n-3 polyunsaturated fatty acids. One of the two study groups (28 volunteers) will take 4 capsules of the active product (blue fish hydrolysate), for 90 days. Each day the capsules will be taken as followed : 2 capsules in the morning and 2 capsules in the evening.

DIETARY_SUPPLEMENT

Placebo

The placebo product containing mainly maltodextrin is presented in the same form as the active product, so that people handling the product cannot distinguish between them. The placebo is flavoured in order to have a fishy smell just like the active product. One of the two study groups (28 volunteers) will take 4 capsules of placebo per day, for 90 days.Each day the capsules will be taken as followed : 2 capsules in the morning and 2 capsules in the evening.

Sponsors & Collaborators

  • Laboratoire Nutrition et Neurobiologie intégrée

    collaborator UNKNOWN

  • University Hospital, Bordeaux

    collaborator OTHER

  • Abyss Ingredients

    lead INDUSTRY

Principal Investigators

  • Pierre PHILIP, Pr · University Hospital, Bordeaux

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
73 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-14
Primary Completion
2023-08-10
Completion
2023-08-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04910399 on ClinicalTrials.gov